ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/04 | 1,197 | 1,263 | 1,134 | 1,144 | -56 | -4.7% | 830,600 |
2022/03/03 | 1,279 | 1,290 | 1,187 | 1,200 | -45 | -3.6% | 443,900 |
2022/03/02 | 1,239 | 1,295 | 1,223 | 1,245 | -22 | -1.7% | 487,800 |
2022/03/01 | 1,241 | 1,282 | 1,223 | 1,267 | +2 | +0.2% | 517,300 |
2022/02/28 | 1,170 | 1,276 | 1,163 | 1,265 | +72 | +6% | 623,300 |
2022/02/25 | 1,208 | 1,230 | 1,156 | 1,193 | +32 | +2.8% | 410,300 |
2022/02/24 | 1,135 | 1,211 | 1,133 | 1,161 | +38 | +3.4% | 568,600 |
2022/02/22 | 1,107 | 1,174 | 1,105 | 1,123 | -28 | -2.4% | 458,000 |
2022/02/21 | 1,133 | 1,182 | 1,108 | 1,151 | -29 | -2.5% | 342,100 |
2022/02/18 | 1,141 | 1,189 | 1,124 | 1,180 | -5 | -0.4% | 484,100 |
2022/02/17 | 1,200 | 1,223 | 1,158 | 1,185 | -13 | -1.1% | 615,700 |
2022/02/16 | 1,105 | 1,219 | 1,105 | 1,198 | +153 | +14.6% | 1,457,000 |
2022/02/15 | 1,010 | 1,086 | 996 | 1,045 | +42 | +4.2% | 307,600 |
2022/02/14 | 1,009 | 1,015 | 968 | 1,003 | -36 | -3.5% | 422,200 |
2022/02/10 | 1,047 | 1,061 | 1,036 | 1,039 | +4 | +0.4% | 155,900 |
2022/02/09 | 1,047 | 1,047 | 999 | 1,035 | -15 | -1.4% | 280,600 |
2022/02/08 | 1,034 | 1,065 | 1,027 | 1,050 | +1 | +0.1% | 128,800 |
2022/02/07 | 1,056 | 1,069 | 1,036 | 1,049 | -6 | -0.6% | 100,300 |
2022/02/04 | 1,050 | 1,059 | 1,022 | 1,055 | -11 | -1% | 154,500 |
2022/02/03 | 1,072 | 1,085 | 1,059 | 1,066 | -36 | -3.3% | 132,900 |
2022/02/02 | 1,060 | 1,105 | 1,060 | 1,102 | +55 | +5.3% | 88,800 |
2022/02/01 | 1,040 | 1,096 | 1,040 | 1,047 | +10 | +1% | 162,700 |
2022/01/31 | 1,037 | 1,050 | 1,018 | 1,037 | +4 | +0.4% | 131,000 |
2022/01/28 | 1,089 | 1,100 | 1,020 | 1,033 | -33 | -3.1% | 222,500 |
2022/01/27 | 1,086 | 1,095 | 1,060 | 1,066 | -4 | -0.4% | 258,600 |
2022/01/26 | 1,034 | 1,096 | 1,034 | 1,070 | +20 | +1.9% | 193,100 |
2022/01/25 | 1,142 | 1,158 | 1,029 | 1,050 | -18 | -1.7% | 407,000 |
2022/01/24 | 1,029 | 1,076 | 1,025 | 1,068 | +35 | +3.4% | 218,500 |
2022/01/21 | 1,059 | 1,068 | 1,023 | 1,033 | -50 | -4.6% | 254,600 |
2022/01/20 | 1,071 | 1,093 | 1,062 | 1,083 | +12 | +1.1% | 168,600 |
2022/01/19 | 1,110 | 1,114 | 1,065 | 1,071 | -72 | -6.3% | 296,500 |
2022/01/18 | 1,147 | 1,166 | 1,131 | 1,143 | -4 | -0.3% | 142,700 |
2022/01/17 | 1,186 | 1,191 | 1,142 | 1,147 | -41 | -3.5% | 205,800 |
2022/01/14 | 1,205 | 1,213 | 1,180 | 1,188 | -43 | -3.5% | 446,400 |
2022/01/13 | 1,271 | 1,294 | 1,231 | 1,231 | -70 | -5.4% | 220,200 |
2022/01/12 | 1,270 | 1,302 | 1,261 | 1,301 | +58 | +4.7% | 142,800 |
2022/01/11 | 1,201 | 1,251 | 1,195 | 1,243 | +33 | +2.7% | 276,800 |
2022/01/07 | 1,201 | 1,220 | 1,194 | 1,210 | +8 | +0.7% | 206,600 |
2022/01/06 | 1,239 | 1,272 | 1,193 | 1,202 | -67 | -5.3% | 355,500 |
2022/01/05 | 1,254 | 1,275 | 1,234 | 1,269 | +1 | +0.1% | 176,000 |
2022/01/04 | 1,281 | 1,281 | 1,235 | 1,268 | -15 | -1.2% | 213,500 |
2021/12/30 | 1,330 | 1,330 | 1,283 | 1,283 | -52 | -3.9% | 309,000 |
2021/12/29 | 1,309 | 1,355 | 1,309 | 1,335 | +22 | +1.7% | 168,800 |
2021/12/28 | 1,327 | 1,338 | 1,287 | 1,313 | +1 | +0.1% | 212,100 |
2021/12/27 | 1,351 | 1,351 | 1,290 | 1,312 | -53 | -3.9% | 237,200 |
2021/12/24 | 1,334 | 1,381 | 1,323 | 1,365 | +41 | +3.1% | 214,700 |
2021/12/23 | 1,377 | 1,383 | 1,311 | 1,324 | -33 | -2.4% | 280,700 |
2021/12/22 | 1,319 | 1,375 | 1,311 | 1,357 | +66 | +5.1% | 329,500 |
2021/12/21 | 1,301 | 1,306 | 1,255 | 1,291 | +9 | +0.7% | 301,100 |
2021/12/20 | 1,240 | 1,314 | 1,240 | 1,282 | +54 | +4.4% | 420,500 |
851~
900
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム